Home Supplements How We Rate Blog
Oleuropein (Olea europaea leaf compound)

Oleuropein

Research reviewed: 2025-2026

Oleuropein (Oleuropein (Olea europaea leaf compound)) is a dietary supplement with 7 published peer-reviewed studies involving 1,391 participants, researched for Cardiovascular & Antioxidant, Heart Health.

7
Studies
1,391
Participants
2011–2026
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Cardiovascular & Antioxidant

Strong
2 studies 2 of 2 positive 106 participants

Heart Health

Moderate
5 studies 1 of 5 positive 1,391 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

2/7
Randomised
2/7
Double-Blind
2/7
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2011)
60
Study 2 (2013)
46
Study 3 (2026)
110
Study 4 (2025)
26
Study 5 (2025)
621
Study 6 (2025)
40
Study 7 (2025)
594

Research Timeline

When the studies were published

1
2011
1
2013
4
2025
1
2026

All Studies

Detailed breakdown of each trial. Click to expand.

Cardiovascular & Antioxidant

1

To assess olive leaf extract (standardised to oleuropein) on blood pressure.

2011 60 participants 8 weeks Olive leaf extract 500mg (containing 100mg oleuropein) twice...
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess olive leaf extract (standardised to oleuropein) on blood pressure.

Dose

Olive leaf extract 500mg (containing 100mg oleuropein) twice daily

Participants

60 stage 1 hypertensive adults

Duration

8 weeks

Results

Olive leaf extract significantly reduced systolic BP by 11.5 mmHg and diastolic by 4.8 mmHg vs placebo. LDL cholesterol also reduced. Comparable to captopril 25mg twice daily.

How They Measured It

Systolic and diastolic blood pressure, heart rate, lipid profile

Read full study
2

To evaluate olive leaf extract effect on insulin sensitivity in overweight adults.

2013 46 participants 12 weeks Olive leaf extract 51.1mg oleuropein daily
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate olive leaf extract effect on insulin sensitivity in overweight adults.

Dose

Olive leaf extract 51.1mg oleuropein daily

Participants

46 overweight middle-aged men

Duration

12 weeks

Results

Olive leaf extract significantly improved insulin sensitivity (by 15%) and pancreatic beta-cell responsiveness. Oleuropein may prevent type 2 diabetes development.

How They Measured It

Insulin secretion, insulin sensitivity, glucose metabolism (clamp technique)

Read full study

Heart Health

3

The impact of olive oil polyphenol supplementation on metabolic syndrome parameters The OleoMetS study: A randomized, controlled clinical trial.

2026 110 participants 12 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

The impact of olive oil polyphenol supplementation on metabolic syndrome parameters The OleoMetS study: A randomized, controlled clinical trial.

Dose

See study

Participants

110 participants

Duration

12 weeks

Results

CONCLUSION: Supplementation with OOPs shows promise in improving key metabolic markers in patients with MetS.

How They Measured It

PubMed PMID: 41429309. Clin Nutr ESPEN

Read full study
4

Effects of olive leaf extract supplementation on systemic markers of tissue aging and remodeling in postmenopausal women: a randomized controlled tria

2025 26 participants 12 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

Effects of olive leaf extract supplementation on systemic markers of tissue aging and remodeling in postmenopausal women: a randomized controlled tria

Dose

See study

Participants

26 participants

Duration

12 weeks

Results

CONCLUSION: The exploratory skin analyses revealed a reduction in pore number and surface skewness, suggesting that OLE may exert localized effects on skin structure.

How They Measured It

PubMed PMID: 41340653. Front Nutr

Read full study
5

Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial.

2025 621 participants 12 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial.

Dose

See study

Participants

621 participants

Duration

12 weeks

Results

CONCLUSION: OLE can decrease 24-h BP, BPL, and diastolic BPV with improvement of lipid profile, systemic inflammation, and body weight in hypertensive patients.

How They Measured It

PubMed PMID: 40990594. J Hypertens

Read full study
6

Oleuropein Supplementation Increases Resting Skeletal Muscle Fractional Pyruvate Dehydrogenase Activity but Does Not Influence Whole-Body Metabolism:

2025 40 participants Not specified See study
Human Study Mixed

Study Type

RCT

Purpose

Oleuropein Supplementation Increases Resting Skeletal Muscle Fractional Pyruvate Dehydrogenase Activity but Does Not Influence Whole-Body Metabolism:

Dose

See study

Participants

40 participants

Duration

Not specified

Results

CONCLUSIONS: Chronic OLE supplementation resulted in higher skeletal muscle fractional PDH activity in healthy, older males, which may impact resting energy metabolism.

How They Measured It

PubMed PMID: 39993475. J Nutr

Read full study
7

The impact of oleuropein, hydroxytyrosol, and tyrosol on cardiometabolic risk factors: a meta-analysis of randomized controlled trials.

2025 594 participants Not specified See study
Human Study Positive

Study Type

Meta-Analysis

Purpose

The impact of oleuropein, hydroxytyrosol, and tyrosol on cardiometabolic risk factors: a meta-analysis of randomized controlled trials.

Dose

See study

Participants

594 participants

Duration

Not specified

Results

significantly reduced total cholesterol (SMD = -0.

How They Measured It

PubMed PMID: 39828996. Crit Rev Food Sci Nutr

Read full study

Frequently Asked Questions

Common questions about Oleuropein research

What does the research say about Oleuropein?

There are currently 7 peer-reviewed studies on Oleuropein (Oleuropein (Olea europaea leaf compound)), involving 1,391 total participants. Research covers Cardiovascular health, Antioxidant protection, Anti-inflammatory and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Oleuropein?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (7 human studies), and reported outcomes.

What health goals has Oleuropein been studied for?

Oleuropein has been researched for: Cardiovascular health, Antioxidant protection, Anti-inflammatory, Antiviral. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Oleuropein based on human trials?

Yes, 7 out of 7 studies are human trials. Human trials carry more weight in our evidence scoring system.